Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
52,079,102
-
Share change
-
+4,614,364
-
Total reported value
-
$1,493,009,720
-
Put/Call ratio
-
221%
-
Price per share
-
$28.65
-
Number of holders
-
112
-
Value change
-
+$129,908,137
-
Number of buys
-
63
-
Number of sells
-
44
Institutional Holders of DICE THERAPEUTICS INC - COM (DICE) as of Q1 2023
As of 31 Mar 2023,
DICE THERAPEUTICS INC - COM (DICE) was held by
112 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,079,102 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., FMR LLC, Avoro Capital Advisors LLC, Northpond Ventures, LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., Sands Capital Ventures, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, and Deep Track Capital, LP.
This page lists
112
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.